Category Covid-19

PIER MARIA FORNASARI
2021-03-12

Obesity linked to higher risk for poor COVID-19 outcomes

The risk for invasive mechanical ventilation, hospitalization and death in those with COVID-19 increased with BMI, according to research published in MMWR. “The findings in this report highlight a dose-response relationship between higher BMI and severe COVID-19–associated illness and underscore the need for progressively intensive illness management as obesity severity increases,” LyudmylaKompaniyets, PhD, a postdoctoral research fellow at the CDC,

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-12

Protease inhibitors drugs Camostat and Nafamostat inhibit new SARS-CoV-2 activators identified in the upper respiratory tract, blocking virus cell entry.

There are no therapeutics available that have been developed for COVID-19 treatment. Repurposing of already available medication for COVID-19 therapy is an attractive option to shorten the road to treatment development. The drug Camostat could be suitable. Camostat exerts antiviral activity by blocking the protease TMPRSS2, which is used by SARS-CoV-2 for entry into cells.

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-12

UK Royal College of Physicians calls for urgent measures to protect and safeguard medical workforce involved in fight against Covid-19

In an article published in The Lancet, RCP president Professor Andrew Goddard and RCP Global vice president Dr Mumtaz Patel call for system-wide support to protect clinicians from harm. The COVID-19 pandemic has placed huge demands on global health systems which are testing doctors and health-care workers to the limits of their professional competence and taking

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-12

A new study on BMJ shows an increase in deaths from 2.5 to 4.1 per 1000 detected cases in SARS-CoV-2 B.1.1.7 variant

A highly infectious variant of COVID-19 that has spread around the world since it was first discovered in Britain late last year is between 30% and 100% more deadly than previous dominant variants, researchers said on Wednesday. In a study that compared death rates among people in Britain infected with the new SARS-CoV-2 variant known

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-06

NIH/NIDDK Researchers propose that masking induced humidity, hydrating the respiratory tract, may lessen severity of COVID-19

Masks help protect the people wearing them from getting or spreading SARS-CoV-2, the virus that causes COVID-19, but now researchers have added evidence for yet another potential benefit for wearers: The humidity created inside the mask may help combat respiratory diseases such as COVID-19. Masks help protect the people wearing them from getting or spreading

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-06

Neurologic Involvement in Children and Adolescents Hospitalized in the US for COVID-19 or MISC

Most are transient, but some develop into life-threatening disorders Neurologic symptoms occurred frequently in children and adolescents hospitalized with COVID-19, a large case series of pediatric patients in the U.S. showed. Of 1,695 people 21 or younger hospitalized for acute COVID-19 or multisystem inflammatory syndrome in children (MIS-C), more than one in five (22%) had

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-05

New Google-Backed Database Tracks Details on SARS-CoV-2 and Variants Cases Worldwide

A group of US and European epidemiologists on Tuesday launched an open international database that presents granular information on 5 million anonymized COVID-19 cases from more than 100 countries. Each case record in the database, which is housed at Global.health, contains up to 40 variables, including information such as the patient’s demographics and location, the date

Read More

No Comments InCovid-19